First-Line Antibiotic Therapy for Streptococcal Infections

Primary Treatment Regimen for Non-Allergic Patients

The American Academy of Family Physicians recommends penicillin V as the drug of choice for children, with a dosing of 250 mg twice or three times daily for 10 days 1
The American Academy of Family Physicians recommends penicillin V for adolescents and adults, with a dosing of 250 mg four times daily OR 500 mg twice daily for 10 days 1, 3
Amoxicillin is equally effective and often preferred in young children due to better palatability, with a dosing of 50 mg/kg once daily (maximum 1,000 mg) OR 25 mg/kg twice daily (maximum 500 mg) for 10 days 1
Intramuscular benzathine penicillin G should be used when oral compliance is uncertain, with a dosing of 600,000 units as single dose for patients less than 27 kg, and 1,200,000 units as single dose for patients 27 kg or greater 1, 3

For non-immediate penicillin allergies, first-generation cephalosporins are preferred, with cephalexin dosing at 20 mg/kg per dose twice daily (maximum 500 mg/dose) for 10 days, and cefadroxil dosing at 30 mg/kg once daily (maximum 1 g) for 10 days 1, 5
For immediate/anaphylactic penicillin allergies, clindamycin is the preferred alternative, with a dosing of 7 mg/kg per dose three times daily (maximum 300 mg/dose) for 10 days 1, 5
Macrolide alternatives, such as azithromycin, can be used, with a dosing of 12 mg/kg once daily (maximum 500 mg) for 5 days only 1, 5

A full 10-day course is mandatory for all antibiotics except azithromycin to achieve maximal pharyngeal eradication and prevent acute rheumatic fever 1, 2, 3
Azithromycin is the only exception, requiring only 5 days due to its prolonged tissue half-life 1, 5

Combination therapy with clindamycin PLUS penicillin is mandatory for necrotizing fasciitis and streptococcal toxic shock syndrome, with clindamycin dosing at 600-900 mg every 8 hours IV, and penicillin dosing at 2-4 million units every 4-6 hours IV 8

Sulfonamides or tetracyclines should not be used for Group A streptococcal pharyngitis due to high resistance rates and frequent treatment failures 2, 4
Trimethoprim-sulfamethoxazole has 50% resistance and is not recommended 5
Macrolide resistance among Group A Streptococcus ranges from 5-8% in the United States, and local resistance patterns should be checked before prescribing macrolides 1, 5

Analgesics/antipyretics, such as acetaminophen or NSAIDs, can be used for moderate to severe symptoms, but aspirin must be avoided in children due to Reye syndrome risk 1, 5
Corticosteroids are not recommended as adjunctive therapy for Group A streptococcal pharyngitis 1, 5